Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind parallel study of human fibrinogen in hypofibrinogenemia
CTR20131143Phase 3Completed
- Sponsor
- Tonrol Biopharmaceuticals
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in hypofibrinogenemia, sponsored by Tonrol Biopharmaceuticals. Started May 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
hypofibrinogenemia
Beyond the preview
Go deeper on CTR20131143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131143.